Journal article
Multiterritory Brain Infarcts, Anticoagulation, and Recurrence After Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA Trial.
Abstract
BACKGROUND: In patients with cryptogenic stroke, the characteristics of multiterritory brain infarcts, the recurrent stroke risk, and the response to anticoagulation remain unclear.
METHODS: The ARCADIA trial (Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke) screened patients with cryptogenic stroke for atrial cardiopathy at 185 centers in the United States and Canada from 2018 to 2022. Investigators reported …
Authors
Gologorsky R; Lansberg MG; Wintermark M; Cassarly CN; Aragon Garcia R; Plummer P; Karunamuni N; Kasner SE; Navi BB; Liberman A
Journal
Stroke, , ,
Publisher
Wolters Kluwer
Publication Date
December 5, 2025
DOI
10.1161/strokeaha.125.053079
ISSN
0039-2499